| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/28/2002 | US20020025929 Concurrent aministering parathyroid hormone and benzothiophene compound |
| 02/28/2002 | US20020025577 Eukaryotic gene expression cassette and uses thereof |
| 02/28/2002 | US20020025350 Dietary supplements |
| 02/28/2002 | US20020025347 Administering a metabolite of a Salviae Miltiorrhizae Radix herb to the diabetic individual for therapy of diabetic nephropathy |
| 02/28/2002 | US20020023877 Methods for the production of D-chiro-inositol and the use of D-chiro-inositol obtained therefrom |
| 02/28/2002 | DE10038709A1 Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen Substituted and unsubstituted Benzooxathiazole and compounds derived therefrom |
| 02/28/2002 | CA2456008A1 Stem cell differentiation |
| 02/28/2002 | CA2420499A1 Methods of treatment or prevention of autoimmune diseases with cpg-containing polynucleotide |
| 02/28/2002 | CA2420283A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection |
| 02/28/2002 | CA2420024A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2419580A1 Integrin receptor inhibitors |
| 02/28/2002 | CA2419310A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | CA2418134A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 02/28/2002 | CA2418104A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | CA2411924A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting proteinkinases |
| 02/28/2002 | CA2356058A1 Intermittent administration of a growth hormone secretagogue |
| 02/27/2002 | EP1181954A2 Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (ApoB) secretion |
| 02/27/2002 | EP1181933A2 Use of growth hormone secretagogues for stimulating or increasing appetite |
| 02/27/2002 | EP1181388A2 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 02/27/2002 | EP1181385A2 Modulation of gene expression in gastrointestinal inflammation |
| 02/27/2002 | EP1181367A2 Polynucleotides and membrane-bound polypeptides encoded thereby |
| 02/27/2002 | EP1181364A1 Lipid metabolism transcription factor |
| 02/27/2002 | EP1181316A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 02/27/2002 | EP1181294A1 Novel derivatives and analogues of galanthamin |
| 02/27/2002 | EP1181286A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181285A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 02/27/2002 | EP1181282A2 Benzothiazinone and benzoxazinone compounds |
| 02/27/2002 | EP1181276A1 Morpholino-n-ethyl ester derivative of an indole spla-2 inhibitor |
| 02/27/2002 | EP1181271A2 Naphthalene ureas as glucose uptake enhancers |
| 02/27/2002 | EP1181054A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
| 02/27/2002 | EP1181051A1 METHODS AND COMPOUNDS FOR THE TREATMENT OF IMMUNOLOGICALLY-MEDIATED DISEASES USING i MYCOBACTERIUM VACCAE /i |
| 02/27/2002 | EP1181047A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 02/27/2002 | EP1181043A2 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 02/27/2002 | EP1181042A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area |
| 02/27/2002 | EP1181027A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 02/27/2002 | EP1181020A2 Vitamin d derivatives for the teatment of systemic lupus erythematosus |
| 02/27/2002 | EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 02/27/2002 | EP1181010A1 Pharmaceutical chewing gum formulations |
| 02/27/2002 | EP1180944A1 Compositions containing creatine in suspension |
| 02/27/2002 | EP0792264B1 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 02/27/2002 | CN1337966A Hesperitin pro-forms with enhanced bioavailability |
| 02/27/2002 | CN1337963A Pirazino (aza) indole derivatives |
| 02/27/2002 | CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 02/27/2002 | CN1337958A Compounds and methods for modulation of estroglen receptors |
| 02/27/2002 | CN1337956A New Morpholinobenzamide salts |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337949A Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid as TACE inhibitor |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/27/2002 | CN1337944A Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid as TACE inhibitors |
| 02/27/2002 | CN1337411A Chitosan aliphatic salt with slimming function and its prepn process |
| 02/27/2002 | CN1337253A Superfine powder, concentrate and medicated food product of alfalfa and their application |
| 02/27/2002 | CN1337248A Prepn of antilipemic weight-reducing gynostemma pentaphylla capsule |
| 02/27/2002 | CN1337237A Zanchun wine and its production process |
| 02/27/2002 | CN1337228A Application of lipoic acid for improving biological utilization ratio of mineral salt |
| 02/27/2002 | CN1337227A Soluble liquide preparation of liposoluble matter |
| 02/27/2002 | CN1337180A Medicated food of animal pancreas and its production process |
| 02/27/2002 | CN1079795C Stabilization and recovery method for tocotrienol and tocopherol products |
| 02/27/2002 | CN1079791C Vitamin D. analogues |
| 02/27/2002 | CN1079671C Combination treatment for inhibiting bone loss |
| 02/26/2002 | US6350760 Substituted piperidines as melanocortin-4 receptor agonists |
| 02/26/2002 | US6350758 Tropane derivatives and method for their synthesis |
| 02/26/2002 | US6350747 Protein serine/threonine kinase and protein tyrosine kinase enzyme inhibitors; angiogenesis inhibitors; antitumor and antiproliferative agents |
| 02/26/2002 | US6350735 Purine derivatives |
| 02/26/2002 | US6350457 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 02/26/2002 | CA2237883C Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids |
| 02/26/2002 | CA2222771C Fat based food products |
| 02/26/2002 | CA2078875C High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| 02/26/2002 | CA2046801C Substituted pyrroles |
| 02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
| 02/21/2002 | WO2002014504A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 02/21/2002 | WO2002014477A2 Bioavailable composition of natural and synthetic hca |
| 02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
| 02/21/2002 | WO2002014368A2 Proteins and nucleic acids encoding the same |
| 02/21/2002 | WO2002014360A1 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 02/21/2002 | WO2002014355A2 Novel mitogen activated kinase |
| 02/21/2002 | WO2002014319A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/21/2002 | WO2002014312A1 Tetrazolyl-phenyl acetamide glucokinase activators |
| 02/21/2002 | WO2002014311A2 Urea compounds and methods of uses |
| 02/21/2002 | WO2002014291A1 PPARδ ACTIVATORS |
| 02/21/2002 | WO2002014282A1 2-aminopyridine compounds and use thereof as drugs |
| 02/21/2002 | WO2002014281A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | WO2002014277A1 Biphenylcarboxamidoisoindoline compounds, processes for the preparation of the same and intermediates for the synthesis thereof |
| 02/21/2002 | WO2002014273A1 Indoline derivatives as 5ht2c antagonists |
| 02/21/2002 | WO2002014272A1 (thio)urea derivatives, process for their production and medicines containing the derivatives |
| 02/21/2002 | WO2002014271A1 Proline derivatives and use thereof as drugs |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002014251A1 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 02/21/2002 | WO2002013862A2 Method and composition for altering a b cell mediated pathology |
| 02/21/2002 | WO2002013861A2 Method and composition for altering a t cell mediated pathology |
| 02/21/2002 | WO2002013832A1 Remedial agent for osteoporosis |
| 02/21/2002 | WO2002013821A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | WO2002013814A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| 02/21/2002 | WO2002013813A1 Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |
| 02/21/2002 | WO2002013811A2 Compositions containing hypoglycemically active stilbenoids |
| 02/21/2002 | WO2002013809A2 Compositions containing hypotriglyceridemically active stilbenoids |
| 02/21/2002 | WO2002013806A2 Compositions containing hypotriglyceridemically active stilbenoids |
| 02/21/2002 | WO2002013800A2 Method for the prevention and treatment of retinopathy |